Beijing, China

Wenzhong Li

This inventor holds 1 USPTO granted patent. Top assignees: Bristar Immunotech Limited, Tsinghua University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wenzhong Li. Retrieved from https://idiyas.com/inventor/wenzhong-li-8vogsyhe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wenzhong Li: Innovator in T Cell Antigen Receptor Technology

Introduction

Wenzhong Li is a prominent inventor based in Beijing, China. He has made significant contributions to the field of immunology, particularly in the development of T cell antigen receptors. His innovative work has led to advancements that could have a profound impact on therapeutic applications.

Latest Patents

Wenzhong Li holds a patent for a T cell antigen receptor, multimeric complex thereof, and preparation method therefor and use thereof. This patent represents a crucial step in enhancing the efficacy of immune responses in various medical treatments. He has 1 patent to his name, showcasing his expertise and dedication to innovation in this specialized area.

Career Highlights

Throughout his career, Wenzhong Li has worked with notable organizations, including Bristar Immunotech Limited and Tsinghua University. His roles in these institutions have allowed him to collaborate with leading experts and contribute to groundbreaking research in immunotherapy.

Collaborations

Wenzhong Li has collaborated with esteemed colleagues such as Lemei Jia and Hua Chen. These partnerships have fostered a dynamic exchange of ideas and have been instrumental in advancing their shared research goals.

Conclusion

Wenzhong Li's contributions to the field of immunology through his innovative patent and collaborations highlight his role as a key figure in advancing medical science. His work continues to inspire future developments in T cell therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…